What is Alto Neuroscience's R&D?

Alto Neuroscience (ANRO) reported R&D of $20.29M in Q1 2026.

How has Alto Neuroscience's R&D changed year-over-year?

Alto Neuroscience's R&D increased by 103.5% year-over-year, from $9.97M to $20.29M.

What is the long-term trend for Alto Neuroscience's R&D?

Over 2 years (2023 to 2025), Alto Neuroscience's R&D has grown at a 22.7% compound annual growth rate (CAGR), from $30.29M to $45.62M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Alto Neuroscience ANRO R&D

R&D at other companies

Xenon PharmaceuticalsXENE

$88.51M+44.6%

Acadia PharmaceuticalsACAD

$76.87M-1.8%

Rapport Therapeutics, Inc.RAPP

$32.72M+67.2%

Praxis Precision Medicines, Inc.PRAX

$77.99M+28.3%

MeiraGTx Holdings plcMGTX

$31.98M-2.4%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$14.65M+328%

Segments

By product

See full

ALTO-101$5.36M+453%

ALTO-207$4.14M—

ALTO-100$1.76M+56.9%

ALTO-300$1.51M+63.4%

ALTO-203$6K-99.2%

Other financials

Income statement

See full

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Balance sheet

See full

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Cash flow

See full

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Valuation

See full

Market cap$887.88M+1,358%

Enterprise value$644.49M-958%

Returns & leverage

See full

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alto Neuroscience's R&D?: Alto Neuroscience (ANRO) reported R&D of $20.29M in Q1 2026.
How has Alto Neuroscience's R&D changed year-over-year?: Alto Neuroscience's R&D increased by 103.5% year-over-year, from $9.97M to $20.29M.
What is the long-term trend for Alto Neuroscience's R&D?: Over 2 years (2023 to 2025), Alto Neuroscience's R&D has grown at a 22.7% compound annual growth rate (CAGR), from $30.29M to $45.62M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.